Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | DBH | P09172 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 5/20 | 0.54 |
| ▸ | CA2 | P00918 | 5/20 | 0.54 |
| ▸ | CA12 | O43570 | 4/20 | 0.54 |
| ▸ | CA7 | P43166 | 4/20 | 0.54 |
| ▸ | CA9 | Q16790 | 4/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.54 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.54 |
| ▸ | ESR1 | P03372 | 3/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10121174 | 0.89 | KDM4E (0.62) | KDM4EDBHGAARECQLCA1 | |
| SCHEMBL13687470 | 0.88 | PARP10 (0.58) | KDM4EDBHGAARECQLCA1 | |
| SCHEMBL24473673 | 0.86 | KDM4E (0.47) | KDM4EDBHGAARECQLCA1 | |
| Phenol SCHEMBL14718671 | 0.84 | CES2 (0.50) | KDM4EDBHGAARECQLCA1 | |
| SCHEMBL481087 | 0.83 | CA1 (0.52) | KDM4EDBHGAARECQLCA1 | |
| SCHEMBL10941943 | 0.82 | KDM4E (0.56) | KDM4EDBHGAARECQLESR1 | |
| SCHEMBL12418688 | 0.82 | KDM4E (0.56) | KDM4EDBHGAARECQLPDPK1 | |
| Hydroxylated Completely Delakylated Diethylpropion SCHEMBL27460979 | 0.81 | CA1 (0.50) | CA1CA2CA12CA7CA9 | |
| SCHEMBL2818719 | 0.81 | CA1 (0.50) | CA1CA2CA12CA7CA9 | |
| SCHEMBL27467685 | 0.81 | CA1 (0.50) | KDM4EDBHGAARECQLCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013173332-A1 | METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN | Vertichem Corporation (CA) | 2013-11-21 | — | — | WO | claimed |
| US-20130232853-A1 | METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN | THESIS CHEMISTRY, LLC (US) | 2013-09-12 | — | — | US | claimed |
| US-20130232852-A1 | METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN | THESIS CHEMISTRY, LLC (US) | 2013-09-12 | — | — | US | claimed |
| WO-2013134756-A1 | A METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN | Vertichem Corporation (CA) | 2013-09-12 | — | — | WO | claimed |
| EP-0019151-B1 | USE OF PHENOL-ISOBUTYRALDEHYDE-POLYCONDENSATION PRODUCTS AS LAKING AGENTS FOR BASIC COLORANTS | BASF Aktiengesellschaft (DE) | 1982-02-03 | — | — | EP | claimed |
| EP-4237008-A2 | CARRIER PARTICLE-DRUG CONJUGATES, SELF-IMMOLATIVE LINKERS, AND USES THEREOF | Elucida Oncology, Inc. (US) | 2023-09-06 | — | — | EP | disclosed |
| US-20230241243-A1 | CARRIER PARTICLE-DRUG CONJUGATES, SELF-IMMOLATIVE LINKERS, AND USES THEREOF | ELUCIDA ONCOLOGY, INC. | 2023-08-03 | — | — | US | disclosed |
| US-20230241243-A1 | CARRIER PARTICLE-DRUG CONJUGATES, SELF-IMMOLATIVE LINKERS, AND USES THEREOF | ELUCIDA ONCOLOGY, INC. | 2023-08-03 | — | — | US | disclosed |
| WO-2023028350-A1 | THERAPEUTIC COMPOSITIONS AND RELATED METHODS | BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH, INC. (US) | 2023-03-02 | — | — | WO | disclosed |
| CN-111056890-B | Method for preparing aryl ketone by free radical-free radical coupling reaction of ketoacid decarboxylation and fatty aldehyde decarbonylation based on iron catalysis | 湘潭大学 | 2022-10-14 | — | — | CN | disclosed |
| WO-2022093800-A2 | CARRIER PARTICLE-DRUG CONJUGATES, SELF-IMMOLATIVE LINKERS, AND USES THEREOF | ELUCIDA ONCOLOGY, INC. (US) | 2022-05-05 | — | — | WO | disclosed |
| US-20210393557-A1 | Regulators of the Endoplasmic Reticulum Proteostasis Network | THE SCRIPPS RESEARCH INSTITUTE | 2021-12-23 | — | — | US | disclosed |
| WO-1994022835-A2 | HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | ZENECA LIMITED (GB) | 1994-10-13 | — | — | WO | disclosed |
| WO-1994022834-A1 | HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS | ZENECA LIMITED (GB) | 1994-10-13 | — | — | WO | disclosed |
| US-5179229-A | Preparation of 2,2-diorgano-3-arylpropionic acids and esters thereof | HOECHST CELANESE CORPORATION (US) | 1993-01-12 | — | — | US | disclosed |
| US-5026729-A | Lipoxygenase inhibiting compounds | ABBOTT LABORATORIES (US) | 1991-06-25 | — | — | US | disclosed |
| US-5012007-A | Method for producing 1-indanone derivatives | HOECHST CELANESE CORPORATION, A CORP. OF DE | 1991-04-30 | — | — | US | disclosed |
| EP-0421759-A2 | Method for producing 1-indanone derivatives | HOECHST CELANESE CORPORATION (US) | 1991-04-10 | — | — | EP | disclosed |
| EP-0365340-A2 | Copolymers of 4-hydroxystyrene and alkyl substituted-4-hydroxystyrene | HOECHST CELANESE CORPORATION (US) | 1990-04-25 | — | — | EP | disclosed |
| EP-0019151-A1 | Use of phenol-isobutyraldehyde-polycondensation products as laking agents for basic colorants | BASF Aktiengesellschaft (DE) | 1980-11-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210393557-A1 | Regulators of the Endoplasmic Reticulum Proteostasis Network | XBP1, HSPA5, TFEB | KDM4E 3936/4885DBH 2005/4885GAA 44/4885 |
| US-20130232852-A1 | METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN | DCXR, AGL, GLO1 | KDM4E 738/4885DBH 80/4885GAA 324/4885 |
| US-20230241243-A1 | CARRIER PARTICLE-DRUG CONJUGATES, SELF-IMMOLATIVE LINKERS, AND USES THEREOF | NDC1, KIFC1, SDCBP | KDM4E 4310/4885DBH 1438/4885GAA 307/4885 |
| US-20130232853-A1 | METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN | HAAO, HAO2, HACL2 | KDM4E 1827/4885DBH 16/4885GAA 177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.